FORM 8-K

Company

Lexaria Bioscience Corp.

Filed

June 12, 2025

Period of Report

May 14, 2025

Accession Number

0001640334-25-001030

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →